• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

慢性气道疾病中长期湿化治疗的临床实用性。

The clinical utility of long-term humidification therapy in chronic airway disease.

机构信息

University of Auckland, Auckland, New Zealand.

出版信息

Respir Med. 2010 Apr;104(4):525-33. doi: 10.1016/j.rmed.2009.12.016. Epub 2010 Feb 9.

DOI:10.1016/j.rmed.2009.12.016
PMID:20144858
Abstract

AIM

Persistent airway inflammation with mucus retention in patients with chronic airway disorders such as COPD and bronchiectasis may lead to frequent exacerbations, reduced lung function and poor quality of life. This study investigates if long-term humidification therapy with high flow fully humidified air at 37 degrees C through nasal cannulae can improve these clinical outcomes in this group of patients.

METHOD

108 patients diagnosed with COPD or bronchiectasis were randomised to daily humidification therapy or usual care for 12 months over which exacerbations were recorded. Lung function, quality of life, exercise capacity, and measures of airway inflammation were also recorded at baseline, 3 and 12 months.

RESULTS

Patients on long-term humidification therapy had significantly fewer exacerbation days (18.2 versus 33.5 days; p = 0.045), increased time to first exacerbation (median 52 versus 27 days; p = 0.0495) and reduced exacerbation frequency (2.97/patient/year versus 3.63/patient/year; p = 0.067) compared with usual care. Quality of life scores and lung function improved significantly with humidification therapy compared with usual care at 3 and 12 months.

CONCLUSION

Long-term humidification therapy significantly reduced exacerbation days, increased time to first exacerbation, improved lung function and quality of life in patients with COPD and bronchiectasis. Clinical trial registered with www.actr.org.au; Number ACTRN2605000623695.

摘要

目的

患有慢性气道疾病(如 COPD 和支气管扩张症)的患者气道内持续存在炎症和黏液潴留,可能导致频繁恶化、肺功能下降和生活质量降低。本研究旨在探讨通过鼻塞给予 37°C 高流量完全湿化空气进行长期湿化治疗是否能改善此类患者的这些临床结局。

方法

将 108 例诊断为 COPD 或支气管扩张症的患者随机分为每日湿化治疗组或常规护理组,治疗时间为 12 个月,在此期间记录恶化情况。在基线、3 个月和 12 个月时,还记录了肺功能、生活质量、运动能力和气道炎症指标。

结果

长期湿化治疗组的恶化天数明显减少(18.2 天比 33.5 天;p = 0.045),首次恶化时间延长(中位数 52 天比 27 天;p = 0.0495),恶化频率降低(2.97/患者/年比 3.63/患者/年;p = 0.067)。与常规护理相比,湿化治疗组的生活质量评分和肺功能在 3 个月和 12 个月时均显著改善。

结论

长期湿化治疗可显著减少 COPD 和支气管扩张症患者的恶化天数,延长首次恶化时间,改善肺功能和生活质量。临床研究注册于 www.actr.org.au;注册号 ACTRN2605000623695。

相似文献

1
The clinical utility of long-term humidification therapy in chronic airway disease.慢性气道疾病中长期湿化治疗的临床实用性。
Respir Med. 2010 Apr;104(4):525-33. doi: 10.1016/j.rmed.2009.12.016. Epub 2010 Feb 9.
2
Long-term air humidification therapy is cost-effective for patients with moderate or severe chronic obstructive pulmonary disease or bronchiectasis.长期空气湿化疗法对中重度慢性阻塞性肺疾病或支气管扩张症患者具有成本效益。
Value Health. 2014 Jun;17(4):320-7. doi: 10.1016/j.jval.2014.01.007.
3
Exacerbations of chronic obstructive pulmonary disease.慢性阻塞性肺疾病的急性加重
Respir Care. 2003 Dec;48(12):1204-13; discussion 1213-5.
4
Open-label, randomized comparison trial of long-term outcomes of levofloxacin versus standard antibiotic therapy in acute exacerbations of chronic obstructive pulmonary disease.
Respirology. 2007 Jan;12(1):117-21. doi: 10.1111/j.1440-1843.2006.00950.x.
5
Oxygen With Cold Bubble Humidification Is No Better Than Dry Oxygen in Preventing Mucus Dehydration, Decreased Mucociliary Clearance, and Decline in Pulmonary Function.冷气泡湿化吸氧在预防黏液脱水、纤毛清除功能下降和肺功能下降方面并不优于干燥氧气。
Chest. 2016 Aug;150(2):407-14. doi: 10.1016/j.chest.2016.03.035. Epub 2016 Apr 2.
6
Nocturnal non-invasive nasal ventilation in stable hypercapnic COPD: a randomised controlled trial.稳定期高碳酸血症慢性阻塞性肺疾病患者夜间无创经鼻通气:一项随机对照试验。
Thorax. 2009 Jul;64(7):561-6. doi: 10.1136/thx.2008.108274. Epub 2009 Feb 12.
7
Effect of long-term nebulized colistin on lung function and quality of life in patients with chronic bronchial sepsis.长期雾化吸入黏菌素对慢性支气管败血症患者肺功能及生活质量的影响
Intern Med J. 2007 Jul;37(7):495-8. doi: 10.1111/j.1445-5994.2007.01404.x.
8
Surgical therapy for chronic obstructive pulmonary disease.慢性阻塞性肺疾病的外科治疗
Semin Respir Crit Care Med. 2005 Apr;26(2):167-91. doi: 10.1055/s-2005-869537.
9
Long-term oxygen therapy in chronic obstructive pulmonary disease: the use of concentrators and liquid oxygen systems in north-western Greece.慢性阻塞性肺疾病的长期氧疗:希腊西北部地区制氧机和液氧系统的使用情况
Respiration. 2006;73(6):777-82. doi: 10.1159/000094393. Epub 2006 Jun 30.
10
Long-term decline in lung function, utilisation of care and quality of life in modified GOLD stage 1 COPD.改良版GOLD 1期慢性阻塞性肺疾病患者的肺功能、医疗服务利用情况及生活质量的长期下降
Thorax. 2008 Sep;63(9):768-74. doi: 10.1136/thx.2007.093724. Epub 2008 May 27.

引用本文的文献

1
Addressing treatable traits in bronchiectasis through non-pharmacological therapies: a narrative review.通过非药物疗法解决支气管扩张症中可治疗的特征:一项叙述性综述
J Thorac Dis. 2025 Jun 30;17(6):4302-4322. doi: 10.21037/jtd-2024-2106. Epub 2025 Jun 18.
2
Physiological effects and clinical evidence of high-flow nasal cannula during acute exacerbation in COPD patients: A narrative review.慢性阻塞性肺疾病(COPD)患者急性加重期高流量鼻导管吸氧的生理效应及临床证据:一项叙述性综述
J Intensive Med. 2024 Dec 19;5(2):127-133. doi: 10.1016/j.jointm.2024.10.005. eCollection 2025 Apr.
3
Home High-Flow Nasal Cannula in Patients with Chronic Respiratory Failure: A Literature Review and Suggestions for Clinical Practice.
慢性呼吸衰竭患者的家庭高流量鼻导管吸氧:文献综述与临床实践建议
Tuberc Respir Dis (Seoul). 2025 Apr;88(2):264-277. doi: 10.4046/trd.2024.0196. Epub 2025 Feb 18.
4
Home high-flow therapy during recovery from severe chronic obstructive pulmonary disease (COPD) exacerbation: a mixed-methods feasibility randomised control trial.重度慢性阻塞性肺疾病(COPD)加重期恢复期间的家庭高流量治疗:一项混合方法可行性随机对照试验
BMJ Open Respir Res. 2025 Jan 6;12(1):e002698. doi: 10.1136/bmjresp-2024-002698.
5
Association between humidity and respiratory health: the 2016-2018 Korea National Health and Nutrition Examination Survey.湿度与呼吸健康之间的关联:2016 - 2018年韩国国家健康与营养检查调查
Respir Res. 2024 Dec 2;25(1):424. doi: 10.1186/s12931-024-03054-z.
6
Long-Term High-Flow Nasal Therapy in Patients with Bronchiectasis of Different Severity: A Retrospective Cohort Study.不同严重程度支气管扩张症患者的长期高流量鼻导管治疗:一项回顾性队列研究
J Clin Med. 2024 Oct 15;13(20):6146. doi: 10.3390/jcm13206146.
7
Comparing Highs and Flows in Patients With COPD With Chronic Hypercapnic Respiratory Failure.比较慢性高碳酸血症呼吸衰竭的慢性阻塞性肺疾病患者的高潮气量与低潮气量
Respir Care. 2024 Oct 25;69(11):1482-1483. doi: 10.4187/respcare.12447.
8
Effects of high-flow nasal cannula oxygen therapy in bronchiectasis and hypercapnia: a retrospective observational study.高流量鼻导管吸氧疗法对支气管扩张症和高碳酸血症的影响:一项回顾性观察研究。
BMC Pulm Med. 2024 May 2;24(1):217. doi: 10.1186/s12890-024-03037-2.
9
ERS International Congress 2023: highlights from the Respiratory Intensive Care Assembly.2023年欧洲呼吸学会国际大会:呼吸重症监护会议亮点
ERJ Open Res. 2024 Apr 22;10(2). doi: 10.1183/23120541.00886-2023. eCollection 2024 Mar.
10
Home Respiratory Strategies in Patients With COPD With Chronic Hypercapnic Respiratory Failure.慢性高碳酸血症呼吸衰竭的 COPD 患者的家庭呼吸策略。
Respir Care. 2024 Oct 25;69(11):1457-1467. doi: 10.4187/respcare.11805.